The authors of this study showed that weak RAD50 expression was associated with poor prognosis in patients with MSS CRC, and postulated that increased RAD50 expression in MSS CRC could be a tumor suppressive cellular response to prevent further tumor progression [31]. This evidence concerns the gene RAD50 and Marinesco-Sjogren syndrome.